UK REACH application for authorisation: publication of final opinions

The Agency for UK REACH has published final opinions on the following applications for authorisation.

Reference: AFA018-01
Applicant: Siemens Healthcare Diagnostics Products GmbH
Substances: 4-(1,1,3,3-tetramethylbutyl)phenol, ethoxylated (4-tert-OPnEO)
Use: Use of IVD kit reagents on diagnostic analyser systems by professional users.
Reference: AFA018-02
Applicant: Siemens Healthcare Diagnostics Products GmbH
Substances: 4-(1,1,3,3-tetramethylbutyl)phenol, ethoxylated (4-tert-OPnEO)
Use: Use of IVD wash solutions on diagnostic analyser systems by professional users.
Reference: AFA020-01
Applicant: Abbott Laboratories Limited
Substance: 4-(1,1,3,3 tetramethylbutyl)phenol, ethoxylated (4-tert-OPnEO)
Use: Professional use as a surfactant, in Wash Buffer components used in conjunction with Fluorescence in Situ Hybridisation (FISH) test kits and/or their Laboratory Developed Test (LDT) equivalents, in clinical diagnostic use for medical analysis of human tissue and blood samples to identify characteristic genetic abnormalities related to specific disease conditions.
Reference: AFA021-01
Applicant: Becton Dickinson U.K. Limited
Substance: 4-(1,1,3,3 tetramethylbutyl)phenol, ethoxylated (4-tert-OPnEO)
Use: Use of 4-(1,1,3,3 tetramethylbutyl)phenol, ethoxylated (4-tert-OPnEO) for the lysis of different types of cells in order to release the cell contents for subsequence analysis in diagnostics.